Home / DM Clinical Trials Update at 2016 MDF Annual Conference

DM Clinical Trials Update at 2016 MDF Annual Conference

 

Drs. Laurence Mignon, Ph.D., director of clinical development at Ionis Pharmaceuticals, and Michael Horrigan, M.D., chief medical officer at AMO Pharma, present updates on the status of Phase I/II clinical trials current underway at their industry institutions for potential DM1 therapies – at the 2016 MDF Annual Conference.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.